Magnetic resonance relaxometry in quantitative imaging of brain gliomas: A literature review. Review uri icon

Overview

abstract

  • Magnetic resonance (MR) relaxometry is a quantitative imaging method that measures tissue relaxation properties. This review discusses the state of the art of clinical proton MR relaxometry for glial brain tumors. Current MR relaxometry technology also includes MR fingerprinting and synthetic MRI, which solve the inefficiencies and challenges of earlier techniques. Despite mixed results regarding its capability for brain tumor differential diagnosis, there is growing evidence that MR relaxometry can differentiate between gliomas and metastases and between glioma grades. Studies of the peritumoral zones have demonstrated their heterogeneity and possible directions of tumor infiltration. In addition, relaxometry offers T2* mapping that can define areas of tissue hypoxia not discriminated by perfusion assessment. Studies of tumor therapy response have demonstrated an association between survival and progression terms and dynamics of native and contrast-enhanced tumor relaxometric profiles. In conclusion, MR relaxometry is a promising technique for glial tumor diagnosis, particularly in association with neuropathological studies and other imaging techniques.

publication date

  • May 3, 2023

Research

keywords

  • Brain Neoplasms
  • Glioma
  • Magnetic Resonance Imaging

Identity

Scopus Document Identifier

  • 85158869646

Digital Object Identifier (DOI)

  • 10.1177/19714009231173100

PubMed ID

  • 37133228